8-KRegulation FD

CARDINAL HEALTH INC 8-K Report, Regulation FD Disclosure (Jul 31, 2012)

Filed July 31, 2012For Securities:CAH

Summary

Cardinal Health, Inc. (CAH) filed an 8-K on July 31, 2012, reporting a significant development concerning its pharmaceutical distribution business. Express Scripts, Inc. has notified Cardinal Health that it will not renew its pharmaceutical distribution agreement, which is set to expire on September 30, 2012. This agreement has been a substantial revenue driver for Cardinal Health, contributing approximately $9 billion in annual revenue, all classified as bulk sales. This non-renewal represents a material event for Cardinal Health, as it directly impacts a significant portion of its revenue. The company is likely to face a substantial revenue shortfall and will need to address the implications of losing this key customer, which is a consequence of Express Scripts' merger with Medco Health Solutions, Inc. Investors should monitor how Cardinal Health plans to mitigate this revenue loss and the potential impact on its financial performance and strategic direction.

Key Highlights

  • 1Express Scripts, Inc. will not renew its pharmaceutical distribution agreement with Cardinal Health.
  • 2The agreement is set to expire on September 30, 2012.
  • 3The expiring agreement contributed approximately $9 billion in annual revenue to Cardinal Health.
  • 4All revenue from this agreement is classified as bulk sales.
  • 5The decision by Express Scripts is related to its merger with Medco Health Solutions, Inc.
  • 6This event triggers a material impact on Cardinal Health's revenue streams.

Frequently Asked Questions

The 8-K filing is to disclose that Express Scripts, Inc. has informed Cardinal Health, Inc. that it will not renew their pharmaceutical distribution agreement, which expires on September 30, 2012.

The agreement provided approximately $9 billion in annual revenue to Cardinal Health, all classified as bulk sales. This represents a substantial portion of the company's revenue and will require significant strategic adjustments.

The filing indicates that the decision is in connection with the combined pharmaceutical distribution request for proposal issued following Express Scripts' merger with Medco Health Solutions, Inc.

The immediate impact is the imminent loss of a major customer and a significant revenue stream. Cardinal Health will need to focus on replacing this lost revenue and managing its operational and financial strategies accordingly.